1. Home
  2. CORT
  3. CORT News

Latest Corcept Therapeutics Incorporated (CORT) News on July 27, 2024

CORT

Argus Research

3 days ago

CORT: Raising target price to $36.00

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
CORT

GlobeNewswire

4 days ago

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

Navigate Market Turbulence With These 4 Low-Beta Stocks
CORT

Zacks

9 days ago

Navigate Market Turbulence With These 4 Low-Beta Stocks

Zacks.com featured highlights include ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics
CORT

Zacks

9 days ago

Zacks.com featured highlights include ADMA Biologics, American Superconductor, biote, Lincoln Educational Services and Corcept Therapeutics

CORT

Argus Research

10 days ago

CORT: Raising target price to $35.00

What Makes Corcept (CORT) a Good Fit for 'Trend Investing'
CORT

Zacks

11 days ago

What Makes Corcept (CORT) a Good Fit for 'Trend Investing'

High Insider Ownership Growth Companies On US Exchanges In July 2024
CORT

Simply Wall St.

16 days ago

High Insider Ownership Growth Companies On US Exchanges In July 2024

CORT

Argus Research

17 days ago

CORT: Lowering target price to $31.00

CORT

Argus Research

24 days ago

CORT: Raising target price to $33.00

Corcept (CORT) Shares Rise 20% in Three Months: Here's Why
CORT

Zacks

a month ago

Corcept (CORT) Shares Rise 20% in Three Months: Here's Why

Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions
CORT

GlobeNewswire

a month ago

Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions

What Makes Corcept Therapeutics (CORT) a Good Investment Bet?
CORT

Insider Monkey

a month ago

What Makes Corcept Therapeutics (CORT) a Good Investment Bet?

Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?
CORT

Zacks

a month ago

Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?

CORT

MT Newswires

a month ago

Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym

Teva sues Corcept over mifepristone 'monopoly' for rare disorder
CORT

Reuters

a month ago

Teva sues Corcept over mifepristone 'monopoly' for rare disorder

Insider-Owned Growth Companies To Watch On US Exchanges In June 2024
CORT

Simply Wall St.

a month ago

Insider-Owned Growth Companies To Watch On US Exchanges In June 2024

Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?
CORT

Zacks

2 months ago

Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?

Insider Sale: Chief Development Officer William Guyer Sells 10,000 Shares of Corcept ...
CORT

GuruFocus.com

2 months ago

Insider Sale: Chief Development Officer William Guyer Sells 10,000 Shares of Corcept ...

CORT

MT Newswires

2 months ago

Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating

Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
CORT

GlobeNewswire

2 months ago

Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)

Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?
CORT

Zacks

2 months ago

Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?

Insider Sale: Chief Development Officer William Guyer Sells 30,000 Shares of Corcept ...
CORT

GuruFocus.com

2 months ago

Insider Sale: Chief Development Officer William Guyer Sells 30,000 Shares of Corcept ...

Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
CORT

Zacks

2 months ago

Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal

Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal
CORT

Zacks

2 months ago

Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal

CORT

MT Newswires

2 months ago

Corcept Therapeutics Says Phase 3 Hypercortisolism Trial Meets Primary Endpoint; Shares Advance

Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
CORT

GlobeNewswire

2 months ago

Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)

CORT

MT Newswires

2 months ago

Corcept Therapeutics Insider Sold Shares Worth $1,400,000, According to a Recent SEC Filing

3 High Insider Ownership US Growth Companies With Earnings Growth Up To 70%
CORT

Simply Wall St.

2 months ago

3 High Insider Ownership US Growth Companies With Earnings Growth Up To 70%

Pipeline Moves: Phase III completion for Corcept’s relaorilant
CORT

Clinical Trials Arena

2 months ago

Pipeline Moves: Phase III completion for Corcept’s relaorilant

Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations
CORT

Simply Wall St.

3 months ago

Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations

Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
CORT

Zacks

3 months ago

Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
CORT

Insider Monkey

3 months ago

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript

CORT

MT Newswires

3 months ago

Truist Lifts Corcept Therapeutics' PT to $44 From $42 After Raised Kolym Guidance, Keeps Buy Rating

CORT

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Corcept Therapeutics Inc Earnings Call

CORT

GuruFocus.com

3 months ago

Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...

Corcept Therapeutics Inc (CORT) Outperforms Analyst Estimates in Q1 2024
CORT

GuruFocus.com

3 months ago

Corcept Therapeutics Inc (CORT) Outperforms Analyst Estimates in Q1 2024

CORT

Associated Press Finance

3 months ago

Corcept: Q1 Earnings Snapshot

Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
CORT

GlobeNewswire

3 months ago

Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update

Corcept Completes Enrollment in Phase 4 CATALYST Trial
CORT

GlobeNewswire

3 months ago

Corcept Completes Enrollment in Phase 4 CATALYST Trial

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
CORT

GlobeNewswire

3 months ago

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

CORT

Argus Research

3 months ago

CORT: Lowering target price to $18.00

Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study
CORT

Zacks

3 months ago

Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study

Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
CORT

GlobeNewswire

3 months ago

Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome

Corcept (CORT) Upgraded to Strong Buy: Here's What You Should Know
CORT

Zacks

3 months ago

Corcept (CORT) Upgraded to Strong Buy: Here's What You Should Know

Corcept (CORT) Completes Enrollment in Phase II ALS Study
CORT

Zacks

3 months ago

Corcept (CORT) Completes Enrollment in Phase II ALS Study

Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
CORT

GlobeNewswire

3 months ago

Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)

Corcept (CORT) Completes Enrollment in Ovarian Cancer Study
CORT

Zacks

4 months ago

Corcept (CORT) Completes Enrollment in Ovarian Cancer Study

Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer
CORT

GlobeNewswire

4 months ago

Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer

Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndrome
CORT

GlobeNewswire

4 months ago

Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndrome

Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
CORT

Zacks

4 months ago

Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?

Investing in Corcept Therapeutics (NASDAQ:CORT) five years ago would have delivered you a 114% gain
CORT

Simply Wall St.

4 months ago

Investing in Corcept Therapeutics (NASDAQ:CORT) five years ago would have delivered you a 114% gain

Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
CORT

Zacks

4 months ago

Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?

Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?
CORT

Zacks

4 months ago

Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?

Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?
CORT

Zacks

4 months ago

Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?

Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations
CORT

Simply Wall St.

5 months ago

Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations

Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow
CORT

Zacks

5 months ago

Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript
CORT

Insider Monkey

5 months ago

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript

CORT

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Corcept Therapeutics Inc Earnings Call

CORT

Associated Press Finance

5 months ago

Corcept: Q4 Earnings Snapshot

Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ...
CORT

GuruFocus.com

5 months ago

Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ...

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update
CORT

GlobeNewswire

5 months ago

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update

Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
CORT

GlobeNewswire

5 months ago

Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial

Jim Simons Bolsters Position in Corcept Therapeutics Inc
CORT

GuruFocus.com

5 months ago

Jim Simons Bolsters Position in Corcept Therapeutics Inc

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
CORT

GlobeNewswire

6 months ago

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call

Main Street Capital (MAIN) Stock Moves -1.52%: What You Should Know
CORT

Zacks

6 months ago

Main Street Capital (MAIN) Stock Moves -1.52%: What You Should Know

CORT

Associated Press Finance

6 months ago

Avnet: Fiscal Q2 Earnings Snapshot

Avnet Reports Second Quarter 2024 Financial Results
CORT

Business Wire

6 months ago

Avnet Reports Second Quarter 2024 Financial Results

Nomad Foods Declares Initial Quarterly Dividend
CORT

PR Newswire

6 months ago

Nomad Foods Declares Initial Quarterly Dividend

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
CORT

Zacks

6 months ago

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?

CORT

GlobeNewswire

6 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research
CORT

GlobeNewswire

6 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
CORT

Barrons.com

6 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

5 Stocks to Buy on Steady Rise in Personal Spending, Income
CORT

Zacks

6 months ago

5 Stocks to Buy on Steady Rise in Personal Spending, Income

BIG GAME BLITZ: LEGENDARY QUARTERBACK KURT WARNER TEAMS UP WITH BINGO BLITZ TO OFFER $1 MILLION TO LUCKY GAMER IF RECORD NUMBER OF SACKS IS BROKEN ON FEBRUARY 11
CORT

PR Newswire

6 months ago

BIG GAME BLITZ: LEGENDARY QUARTERBACK KURT WARNER TEAMS UP WITH BINGO BLITZ TO OFFER $1 MILLION TO LUCKY GAMER IF RECORD NUMBER OF SACKS IS BROKEN ON FEBRUARY 11

Corcept Appoints Roberto Vieira as President, Oncology
CORT

GlobeNewswire

6 months ago

Corcept Appoints Roberto Vieira as President, Oncology

Barclays Banned From Texas Municipal-Bond Market Over ESG Dispute
CORT

Bloomberg

6 months ago

Barclays Banned From Texas Municipal-Bond Market Over ESG Dispute

CORT

Reuters

6 months ago

GLOBAL MARKETS-Asia stocks eye weekly gain; US inflation data looms

Isabeau Levito edges Amber Glenn in figure skating nationals short program
CORT

NBC Sports

6 months ago

Isabeau Levito edges Amber Glenn in figure skating nationals short program

CORT

Reuters

6 months ago

GLOBAL MARKETS-Asia stocks on track for weekly gain; eyes on US inflation test

CORT

Investing.com

6 months ago

Gold prices struggle before inflation, Fed cues; copper set for strong week

CNX Resources Corporation. (CNX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
CORT

Zacks

6 months ago

CNX Resources Corporation. (CNX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

CORT

Reuters

6 months ago

UPDATE 1-Denmark's Orsted to acquire full ownership of Sunrise Wind from Eversource

CORT

Reuters

6 months ago

Denmark's Orsted to acquire Eversource's 50% share of Sunrise Wind

Guggenheim Says Utilities Stocks Are a Smart Bet for 2024 – Here Are 3 Names to Consider
CORT

TipRanks

6 months ago

Guggenheim Says Utilities Stocks Are a Smart Bet for 2024 – Here Are 3 Names to Consider

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water
CORT

Zacks

6 months ago

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water

Independent Bank Corp. (NASDAQ:INDB) Q4 2023 Earnings Call Transcript
CORT

Insider Monkey

6 months ago

Independent Bank Corp. (NASDAQ:INDB) Q4 2023 Earnings Call Transcript

Acushnet (GOLF) Hits Fresh High: Is There Still Room to Run?
CORT

Zacks

6 months ago

Acushnet (GOLF) Hits Fresh High: Is There Still Room to Run?

20 Large US Cities with the Fewest Homes for Sale
CORT

Insider Monkey

6 months ago

20 Large US Cities with the Fewest Homes for Sale

Energy & Utilities Roundup: Market Talk
CORT

The Wall Street Journal

6 months ago

Energy & Utilities Roundup: Market Talk

The 7 Best High-Yield Dividend Utilities Stocks to Buy Now
CORT

InvestorPlace

6 months ago

The 7 Best High-Yield Dividend Utilities Stocks to Buy Now

Gen Digital (GEN) Gets Dan Levy On Board to Market Norton Genie
CORT

Zacks

6 months ago

Gen Digital (GEN) Gets Dan Levy On Board to Market Norton Genie

Amphastar Pharmaceuticals (AMPH) Gains As Market Dips: What You Should Know
CORT

Zacks

6 months ago

Amphastar Pharmaceuticals (AMPH) Gains As Market Dips: What You Should Know

Main Street Announces Preliminary Estimate of Fourth Quarter 2023 Operating Results
CORT

PR Newswire

6 months ago

Main Street Announces Preliminary Estimate of Fourth Quarter 2023 Operating Results

Are Alarm.com Holdings, Inc. (NASDAQ:ALRM) Investors Paying Above The Intrinsic Value?
CORT

Simply Wall St.

6 months ago

Are Alarm.com Holdings, Inc. (NASDAQ:ALRM) Investors Paying Above The Intrinsic Value?

EPR Properties Announces Tax Status of 2023 Distributions
CORT

Business Wire

6 months ago

EPR Properties Announces Tax Status of 2023 Distributions

Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
CORT

Zacks

6 months ago

Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note

Belden Opens New Customer Innovation Center in Bengaluru, India
CORT

Business Wire

7 months ago

Belden Opens New Customer Innovation Center in Bengaluru, India

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)
CORT

StockStory

7 months ago

Data Analytics Stocks Q3 Recap: Benchmarking Domo (NASDAQ:DOMO)

Is Now The Time To Look At Buying Lumentum Holdings Inc. (NASDAQ:LITE)?
CORT

Simply Wall St.

7 months ago

Is Now The Time To Look At Buying Lumentum Holdings Inc. (NASDAQ:LITE)?

Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
CORT

Zacks

7 months ago

Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024

Share on Social Networks: